Feedback Regulation of Cholesterol Uptake by the LXR–IDOL–LDLR Axis
- 1 November 2012
- journal article
- review article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 32 (11) , 2541-2546
Abstract
Inducible degrader of the low-density lipoprotein receptor (IDOL) is an E3 ubiquitin ligase that mediates the ubiquitination and degradation of the low-density lipoprotein receptor (LDLR). IDOL expression is controlled at the transcriptional level by the cholesterol-sensing nuclear receptor liver X receptor (LXR). In response to rising cellular sterol levels, activated LXR induces IDOL production, thereby limiting further uptake of exogenous cholesterol through the LDLR pathway. The LXR–IDOL–LDLR mechanism for feedback inhibition of cholesterol uptake is independent of and complementary to the sterol regulatory element–binding protein pathway. Since the initial description of the LXR–IDOL pathway, biochemical studies have helped to define the structural basis for both IDOL target recognition and LDLR ubiquitin transfer. Recent work has also suggested links between IDOL and human lipid metabolism.Keywords
This publication has 43 references indexed in Scilit:
- FERM-dependent E3 ligase recognition is a conserved mechanism for targeted degradation of lipoprotein receptorsProceedings of the National Academy of Sciences, 2011
- Mechanism of ubiquitylation by dimeric RING ligase RNF4Nature Structural & Molecular Biology, 2011
- RING domain dimerization is essential for RNF4 functionBiochemical Journal, 2010
- Biological, clinical and population relevance of 95 loci for blood lipidsNature, 2010
- Inhibition of PCSK9: A powerful weapon for achieving ideal LDL cholesterol levelsProceedings of the National Academy of Sciences, 2009
- Merlin and the ERM proteins – regulators of receptor distribution and signaling at the cell cortexTrends in Cell Biology, 2009
- Structural requirements for PCSK9-mediated degradation of the low-density lipoprotein receptorProceedings of the National Academy of Sciences, 2008
- Molecular basis for LDL receptor recognition by PCSK9Proceedings of the National Academy of Sciences, 2008
- Sequence Variations inPCSK9,Low LDL, and Protection against Coronary Heart DiseaseNew England Journal of Medicine, 2006
- Regulation of the mevalonate pathwayNature, 1990